Challenging look at therapeutic trend of chronic kidney disease–mineral bone disorder in children

Implication for health policy/practice/research/medical education

CKD-MBD explains disturbances of calcium, phosphorus, PTH, and vitamin D metabolism in CKD patients. The target management of CKD-MBD is to manage secondary hyperparathyroidism and avoid the development of extraskeletal calcifications. The treatment of these problems in children needs a specific view to achieve adequate growth process and prevention of cardiovascular problems.